1. Home
  2. ZBRA vs NBIX Comparison

ZBRA vs NBIX Comparison

Compare ZBRA & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zebra Technologies Corporation

ZBRA

Zebra Technologies Corporation

HOLD

Current Price

$226.68

Market Cap

10.6B

Sector

Industrials

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$131.62

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZBRA
NBIX
Founded
1969
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6B
13.2B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
ZBRA
NBIX
Price
$226.68
$131.62
Analyst Decision
Buy
Strong Buy
Analyst Count
8
22
Target Price
$321.88
$180.91
AVG Volume (30 Days)
727.1K
1.1M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.95
EPS
8.18
4.67
Revenue
$5,396,000,000.00
$161,626,000.00
Revenue This Year
$13.27
$24.73
Revenue Next Year
$5.43
$13.14
P/E Ratio
$27.61
$28.21
Revenue Growth
8.33
977.51
52 Week Low
$199.05
$108.47
52 Week High
$352.66
$160.18

Technical Indicators

Market Signals
Indicator
ZBRA
NBIX
Relative Strength Index (RSI) 53.73 53.32
Support Level $199.75 $124.62
Resistance Level $243.69 $135.30
Average True Range (ATR) 7.45 3.41
MACD -0.58 0.17
Stochastic Oscillator 43.27 70.73

Price Performance

Historical Comparison
ZBRA
NBIX

About ZBRA Zebra Technologies Corporation

Zebra Technologies is a leading provider of automatic identification and data capture technology to enterprises. Its solutions include barcode printers and scanners, mobile computers, and workflow optimization software. The firm primarily serves the retail, transportation logistics, manufacturing, and healthcare markets, designing custom solutions to improve efficiency at its customers.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: